发明申请
US20060106023A1 Novel imidazopyrazines as cyclin dependent kinase inhibitors
失效
新型咪唑并吡嗪作为细胞周期蛋白依赖性激酶抑制剂
- 专利标题: Novel imidazopyrazines as cyclin dependent kinase inhibitors
- 专利标题(中): 新型咪唑并吡嗪作为细胞周期蛋白依赖性激酶抑制剂
-
申请号: US11272392申请日: 2005-11-10
-
公开(公告)号: US20060106023A1公开(公告)日: 2006-05-18
- 发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Lianyun Zhao , Patrick Curran , David Belanger , Blake Hamann , Panduranga Reddy , M. Siddiqui
- 申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Lianyun Zhao , Patrick Curran , David Belanger , Blake Hamann , Panduranga Reddy , M. Siddiqui
- 专利权人: Schering Corporation
- 当前专利权人: Schering Corporation
- 主分类号: A61K31/506
- IPC分类号: A61K31/506 ; A61K31/498 ; C07D487/02
摘要:
In its many embodiments, the present invention provides a novel class of imidazo[1,2-a]pyrazine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
公开/授权文献
- US07576085B2 Imidazopyrazines as cyclin dependent kinase inhibitors 公开/授权日:2009-08-18